Discovery Issues Associated with AI Scribe Audio and Audit Trails

Matthew P. Keris
Matthew P. Keris
Marshall Dennehey

Matthew P. Keris chairs Marshall Dennehey’s national EMR and Audit Trail Practice Group and is a recognized authority on electronic medical records in litigation, including audit trail preservation, discovery, and the integration of artificial intelligence into clinical documentation. He is the author of Electronic Medical Records and Litigation (Thomson Reuters Legal, 2014) and has defended health care providers and businesses in complex civil litigation for more than twenty years.

Julie Ritzman
Julie Ritzman
The Doctors Company

Julie Ritzman is Senior Vice President of Patient Safety and Risk Management at The Doctors Company, where her work centers on medical professional liability, patient safety, and health care risk management — the operational side of the clinical documentation, records, and retention practices at issue when claims arise. She previously served as the company’s Vice President of Patient Safety and Risk Management for Region I (2019–2025).

Live Video-Broadcast: October 26, 2026

2 hour CLE

Tuition: $195.00
Subscribe to Federal Bar Association CLE Pass...
Co-Sponsored by myLawCLE
Get this course, plus over 1,000+ of live webinars.
Learn More
Training 5 or more people?

Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs

Program Summary

 

The best evidence of what was actually said is already scheduled for deletion

AI scribes now draft the clinical note from a recorded patient encounter. The recording, not the note, captures what was actually said. Yet vendors delete that audio on short retention windows, often before a plaintiff files suit. The evidence problem is structural: deletion by design, not by accident.

Wait for discovery, and the audio is gone. Demand records under the HIPAA right of access, 45 CFR § 164.524, and the designated record set fight begins. Skip the preservation letter, and the vendor’s deletion clock keeps running. Take the Rule 27 deposition before the motion, and testimony is perpetuated while evidence still exists. Let the note stand unchallenged, and the attestation gap between spoken word and AI-signed note goes unexploited.

Attendees leave with a working framework for identifying what AI scribe data exists and how to demand it. They build a preservation-to-spoliation timeline and learn to cross-examine on hallucination. And they leave with the evidentiary foundation for FRCP 37(e) sanctions, or a state-law adverse inference, when the audio has been destroyed.

Key topics to be discussed:

  • The Deletion Clock
    Mapping AI scribe audio retention windows and the structural evidence problem they create before suit is filed.
  • HIPAA Right of Access
    Deploying 45 CFR § 164.524 and the designated record set argument as pre-suit tools to reach audio the health system classifies as a non-record transitory communication.
  • Pre-Suit Preservation
    Structuring preservation letters, litigation holds, and vendor targeting to stop the deletion clock before litigation begins.
  • The Rule 27 Deposition
    Perpetuating testimony from vendor IT custodians before the motion, when deletion is imminent.
  • Impeaching the Note
    Quantifying the AI scribe error landscape and cross-examining at deposition and trial on the attestation gap between what was spoken and what the AI-signed note says.
  • Spoliation and Sanctions
    Building a preservation-to-spoliation timeline and moving under FRCP 37(e) or state-law adverse inference when the audio has been destroyed.

This course is co-sponsored with myLawCLE.

Date / Time: October 26, 2026

  • 2:30 pm – 4:40 pm Eastern
  • 1:30 pm – 3:40 pm Central
  • 12:30 pm – 2:40 pm Mountain
  • 11:30 am – 1:40 pm Pacific

Closed-captioning available

Speakers

Matthew P. Keris, Shareholder; Chair, EMR and Audit Trail Practice Group | Marshall Dennehey

Matthew P. Keris chairs Marshall Dennehey’s national EMR and Audit Trail Practice Group and is a recognized authority on electronic medical records in litigation, including audit trail preservation, discovery, and the integration of artificial intelligence into clinical documentation. He is the author of Electronic Medical Records and Litigation (Thomson Reuters Legal, 2014) and has defended health care providers and businesses in complex civil litigation for more than twenty years.

  • Education & Credentials

Mr. Keris earned his J.D. from Roger Williams University School of Law in 1996 and his B.A., cum laude, from Shippensburg University of Pennsylvania in 1993. He is admitted to practice in Pennsylvania (1996), New York (2011), and Connecticut (2021), before the U.S. District Courts for the Middle District of Pennsylvania (2000) and the Northern District of New York (2020), and before the U.S. Supreme Court (2023). He is also an Mcare-approved mediator.

  • Recognition & Leadership

Mr. Keris has been listed in The Best Lawyers in America for Medical Malpractice Law – Defendants and Litigation – Health Care and holds Martindale-Hubbell’s AV Preeminent rating. He is a past president of both the DRI Foundation and the Pennsylvania Defense Institute, has served multiple terms as President of the Pennsylvania Association for Health Care Risk Management, and currently serves as editor of Patient Safety.

  • Professional Involvement

Mr. Keris serves on the Healthcare Standards Institute Workgroup on AI Governance Standards and is a member of several professional organizations, including the American Society for Healthcare Risk Management and the Pennsylvania Bar Association Health Care Law Committee. He has also provided commentary to NBC News, Thomson Reuters, Law360, The Legal Intelligencer, and Becker’s Hospital Review.

  • Experience

Mr. Keris speaks frequently on the discovery issues at the center of this program, with recent presentations including “Anticipated AI Discovery Issues in Litigation” (2026), “The Role of AI and EMRs in Discovery” (2025), and “Audit Trail 101” before the Philadelphia Court of Common Pleas (2025). He has also published extensively on artificial intelligence, electronic medical records, and medical negligence in The Legal Intelligencer and the Journal of Healthcare Risk Management. His trial work includes a defense verdict in a long-term care case involving spoliation issues and the first Pennsylvania civil jury trial taken to verdict during the COVID-19 pandemic.

 

Julie Ritzman, MBA, CPHRM, Senior Vice President of Patient Safety and Risk Management | The Doctors Company

Julie Ritzman is Senior Vice President of Patient Safety and Risk Management at The Doctors Company, where her work centers on medical professional liability, patient safety, and health care risk management — the operational side of the clinical documentation, records, and retention practices at issue when claims arise. She previously served as the company’s Vice President of Patient Safety and Risk Management for Region I (2019–2025).

  • Education & Credentials

Ms. Ritzman holds a master’s degree in business administration from the University of South Dakota and is a Certified Professional in Health Care Risk Management (CPHRM). Her credentials are grounded in more than two decades of hands-on health care risk management practice, spanning frontline risk manager roles inside large health systems, executive leadership at a medical professional liability insurer, and national responsibility for patient safety and risk management operations at The Doctors Company  the same claims, documentation, and records-retention environment this program examines from the plaintiff’s side.

  • Recognition & Leadership

Ms. Ritzman serves as Section Chair of the Medical Professional Liability Association Risk Management Committee, following several years of service on that committee. At The Doctors Company, she advanced from Vice President of Patient Safety and Risk Management for Region I to the company’s national senior vice president role, in which she leads a full-time, in-house team of more than 25 patient safety and risk management professionals serving all 50 states and the District of Columbia — every one holding the CPHRM designation and at least ten years of experience — with Patient Safety Centers of Excellence spanning more than 20 specialties.

  • Professional Involvement

Her professional involvement centers on the Medical Professional Liability Association, where she has served on the Risk Management Committee for several years and currently holds the Section Chair role. She is also a national voice for The Doctors Company’s claims-driven patient safety work, serving as a company spokesperson for its 2026 monthly Malpractice Risk Review series, which analyzes real malpractice claims data specialty by specialty to give clinicians actionable insights for strengthening communication, decision making, and overall patient care.

  • Experience

Before joining The Doctors Company, Ms. Ritzman was Vice President of Risk Management Services at the Mutual Insurance Company of Arizona (MICA) from 2014 to 2019. She spent 15 years as a risk manager within large health systems, including Dignity and Sanford Health, giving her an inside view of how health systems manage patient safety events, claims exposure, and the records that document them.

Agenda

SESSION 1 – Pre-Suit Access Requests and Why the Deposition Comes Before the Motion | 2:30pm – 3:30pm ET

This session equips plaintiff attorneys with a sequenced, pre-suit strategy for obtaining AI scribe audio recordings and audit trails before automatic deletion windows close. Attendees will learn how to deploy the HIPAA right of access, preservation letters, and Rule 27 depositions to perpetuate testimony before litigation begins — and before evidence vanishes. Attorneys will leave with a working framework for identifying what AI scribe data exists, how to demand it, and how to structure a pre-suit deposition targeting vendor IT custodians when deletion is imminent.

BREAK | 3:30pm – 3:40pm ET

SESSION 2 – Impeaching the Note with the Audio and Moving When the Audio Is Gone | 3:40pm – 4:40pm ET

This session equips plaintiff attorneys with a concrete framework for using AI scribe audio recordings to impeach AI-generated clinical notes at deposition and trial, and for pursuing spoliation sanctions when those recordings have been deleted. Attendees will learn how to identify and exploit the attestation gap between what was spoken and what the AI-signed note says, how to structure a FRCP 37(e) motion or state-law adverse inference argument when audio has been destroyed, and how to fight the health system’s attempt to classify audio as a non-record transitory communication. By the end of this session, attorneys will be able to build a preservation-to-spoliation timeline, cross-examine on hallucination, and move for sanctions with the right evidentiary foundation.

Credits

Alaska

Approved for CLE Credits
2 General

Our programs are CLE-eligible through Alaska’s recognition of multi-jurisdictional reciprocity.
Alabama

Pending CLE Approval
2 General

Arkansas

Approved for CLE Credits
2 General

Arizona

Approved for CLE Credits
2 General

California

Approved for CLE Credits
2 General

Colorado

Pending CLE Approval
2 General

Connecticut

Approved for CLE Credits
2 General

District of Columbia

No MCLE Required
2 CLE Hour(s)

Delaware

Pending CLE Approval
2 General

Florida

Pending CLE Approval
2 General

Georgia

Pending CLE Approval
2 General

Hawaii

Approved for CLE Credits
2 General

Iowa

Pending CLE Approval
2 General

Idaho

Pending CLE Approval
2 General

Illinois

Pending CLE Approval
2 General

Indiana

Pending CLE Approval
2 General

Kansas

Pending CLE Approval
2 Substantive

Kentucky

Pending CLE Approval
2 General

Louisiana

Pending CLE Approval
2 General

Massachusetts

No MCLE Required
2 CLE Hour(s)

Maryland

No MCLE Required
2 CLE Hour(s)

Maine

Pending CLE Approval
2 General

Michigan

No MCLE Required
2 CLE Hour(s)

Minnesota

Pending CLE Approval
2 General

Missouri

Approved for CLE Credits
2.4 General

Mississippi

Pending CLE Approval
2 General

Montana

Pending CLE Approval
2 General

North Carolina

Pending CLE Approval
2 General

North Dakota

Approved for CLE Credits
2 General

Our programs are CLE-eligible through North Dakota’s recognition of multi-jurisdictional reciprocity. Section 1, Policy 1.14
Nebraska

Pending CLE Approval
2 General

myLawCLE reports attendance to Nebraska on each attorney’s behalf for all programs. Please do not self-report.
New Hampshire

Approved for CLE Credits
120 General minutes

As of July 1, 2014, the NHMCLE Board no longer provides pre- or post-approval of courses. Attendees must self-determine whether a program is eligible for credit, and self-report their attendance online at www.nhbar.org, based on qualification provisions of Rule 53.
New Jersey

Approved for CLE Credits
2 General

Our programs are CLE-eligible through New Jersey’s recognition of multi-jurisdictional reciprocity, except for the courses required under BCLE Reg. 201:2
New Mexico

Approved for CLE Credits
2 General

Nevada

Pending CLE Approval
2 General

New York

Approved for CLE Credits
2 General

Our programs are CLE-eligible through New York’s Approved Jurisdiction Group “B”.
Ohio

Pending CLE Approval
2 General

Oklahoma

Pending CLE Approval
2.5 General

Oregon

Pending CLE Approval
2 General

Pennsylvania

Approved for CLE Credits
2 General

Rhode Island

Pending CLE Approval
2.5 General

South Carolina

Pending CLE Approval
2 General

South Dakota

No MCLE Required
2 CLE Hour(s)

Tennessee

Pending CLE Approval
2 General

Texas

Approved for CLE Credits
2 General

Utah

Pending CLE Approval
2 General

Virginia

Not Eligible
2 General Hours

Vermont

Approved for CLE Credits
2 General

Washington

Approved via Attorney Submission
2 Law & Legal Hours

Receive CLE credit in Washington via attorney submission.
Wisconsin

Pending CLE Approval
2 General

West Virginia

Pending CLE Approval
2.4 General

Wyoming

Pending CLE Approval
2 General

More CLE Webinars
Upcoming CLE Webinars
Derivatives, Digital Assets, and AI in Financial Markets
Derivatives, Digital Assets, and AI in Financial Markets Fri, September 11, 2026
Live Webcast